VistaGen Therapeutics Inc (VTGN) — Strategic Asset Allocation Index
VistaGen Therapeutics Inc (VTGN) has a Strategic Asset Allocation Index of 6.9% as of June 2023. Strategic assets (PP&E of $475.80K plus long-term investments of $-) total $475.80K, measured against net assets of $6.85 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See VTGN net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
VistaGen Therapeutics Inc Strategic Asset Allocation Index (2017–2023)
This chart shows how VistaGen Therapeutics Inc's Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2023. As of June 2023, the index stands at 6.9%, representing strategic assets of $475.80K against net assets of $6.85 Million USD. For live market cap and overall valuation, see VTGN market cap.
Annual Strategic Asset Allocation Index for VistaGen Therapeutics Inc (2017–2023)
The table below presents the year-by-year Strategic Asset Allocation Index for VistaGen Therapeutics Inc from 2017 to 2023, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See VistaGen Therapeutics Inc (VTGN) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 22.9% | $2.77 Million | $2.77 Million | $- | $12.08 Million | ▲ +22.3 pp |
| 2022 | 0.6% | $414.30K | $414.30K | $- | $64.72 Million | ▼ -3.3 pp |
| 2021 | 3.9% | $3.59 Million | $3.59 Million | $- | $91.98 Million | ▼ -0.5 pp |
| 2019 | 4.4% | $312.70K | $312.70K | $- | $7.08 Million | ▲ +1.4 pp |
| 2018 | 3.0% | $207.40K | $207.40K | $- | $6.92 Million | ▼ -43.5 pp |
| 2017 | 46.5% | $286.50K | $286.50K | $- | $615.80K | — |